Overcoming resistance to alpha PD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of alpha CTLA-4 and alpha PD-1 blockers (vol 10, e005059, 2022)
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要